Dose Range Checking
Dose range checking validates orders against weight, renal function, and age, with pediatric weight-based dosing handled as a distinct calculation path.
Custom Software
AI Medication Error Prevention Software Development
AI medication error prevention software applies machine learning and rules logic to ordering, verification, and administration steps to catch dose, route, and patient-matching errors before they reach the patient. It supports nursing and pharmacy workflow only: the nurse administers and the pharmacist verifies, and no medication is ever given or approved automatically.
Medication safety technology has a well-documented failure mode: safeguards that slow work get worked around, and workarounds reintroduce exactly the errors the technology was meant to prevent. Taction Software builds AI medication error prevention designed around that reality, targeting the errors with the worst consequences rather than alerting on everything detectable.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is AI Medication Error Prevention Software
AI medication error prevention refers to software applied across the medication process: dose range checking at ordering, pharmacy verification support, barcode-assisted administration, high-alert drug safeguards, and independent double-check workflow. The design principle that matters is selectivity. Alerting on every theoretical issue produces override behavior that ignores the serious ones too, so the useful system is quiet about low-risk situations and firm about dangerous ones. This work sits inside our broader healthcare AI practice.
Pharmacy Verification Support
Pharmacy verification tooling surfaces the specific concern for each flagged order, so the pharmacist evaluates a stated issue rather than a generic warning.
Barcode Administration Support
Barcode administration confirms patient, drug, dose, and timing matches, designed so scanning is faster than the workaround it replaces.
High-Alert Drug Safeguards
High-alert medications including insulin, anticoagulants, and concentrated electrolytes receive stronger safeguards proportionate to their consequence severity.
Independent Double-Check Workflow
Independent double-check requirements are supported rather than replaced, since software confirmation is not equivalent to a second clinician verifying independently.
Decision Support Boundaries
Every output carries clinical decision support framing. The software does not administer medication, approve orders, override clinicians, or make treatment decisions.
Core AI Medication Error Prevention Services
Our AI medication error prevention services cover ordering integration, verification workflow, administration support, device integration, and alert governance. Alert governance is listed as a service deliberately, because the difference between a safety system that works and one that gets bypassed is almost entirely threshold design. Engagements typically open with a review of current override rates, reported error patterns, and where workarounds have already emerged. Deliverables are structured so pharmacy, nursing, informatics, and medication safety committees can review independently.
01
Order Entry Integration
Integration connects with ordering workflow, building on our computerized order entry work for prescriber-facing checking at the point of order.
02
Verification Workflow Tooling
Verification tooling presents flagged orders with the specific concern identified, replacing generic alerts that pharmacists learn to dismiss reflexively.
03
Administration Support Systems
Administration tooling supports barcode scanning with fast failure handling, since slow exception paths are what drive scanning workarounds on busy units.
04
Device and Pump Integration
Smart pump integration supports dose limit configuration and programming confirmation where pump platforms expose the necessary interfaces.
05
Medication Reconciliation Linkage
Error prevention depends on accurate lists, connecting with AI medication reconciliation for regimen accuracy at transitions.
06
Alert Governance and Tuning
We build alert governance tooling so your medication safety committee can monitor override rates by alert type and retire alerts that produce noise.
Benefits of AI Medication Error Prevention Software
The benefits of AI medication error prevention concentrate in catching high-consequence errors, reducing alert noise, and producing data on where the process actually fails. Most medication safety systems generate far more alerts than actionable findings, which trains clinicians to dismiss them. Selective alerting with visible override data lets your committee tune toward signal. We publish no figures on error reduction or harm prevention, because those depend on your current systems, staffing, and reporting culture, and error rate claims are particularly unreliable given reporting variation.
Focus on High-Consequence Errors
Prioritizing high-alert medications concentrates safeguards where errors cause serious harm rather than distributing attention evenly across all orders.
Reduced Alert Noise
Selective thresholds reduce override behavior, which matters because clinicians dismissing routine alerts also dismiss the important ones.
Visible Failure Points
Override and exception data show where the medication process actually breaks, which is frequently different from where committees assume.
Support for Double-Checks
Structured verification workflow supports independent double-checks properly rather than allowing software confirmation to substitute for a second clinician.
Pediatric Dosing Safety
Distinct weight-based dosing paths address a population where calculation errors carry disproportionate consequence and standard adult logic fails.
Event Reporting Continuity
Near-miss and error data feed quality review through incident reporting software for event analysis.
Our AI Medication Error Prevention Process
We deliver AI medication error prevention projects in gated phases so pharmacy, nursing, and safety stakeholders approve direction before engineering cost accumulates. Discovery establishes intended use, current override rates, and where workarounds have emerged, because existing workarounds are the most reliable evidence of where prior safeguards failed. Development is iterative with pharmacist and bedside nurse review. Alert thresholds are set with your medication safety committee before launch rather than tuned reactively after clinicians begin ignoring them.
Discovery and Override Baseline
Discovery defines intended use and measures existing override rates, since current dismissal behavior predicts how new alerts will be received.
Workaround Identification
We identify existing workarounds, since staff bypassing scanning or verification steps reveals precisely where prior safeguards conflicted with workflow.
Threshold Design With Committee
Alert thresholds are set with your medication safety committee before launch, treating selectivity as a clinical decision rather than a configuration default.
Workflow Testing at Bedside
Administration tooling is tested under real conditions, because a scanning path slower than the workaround will not be adopted regardless of its safety value.
Silent Mode Verification
Where models are used, they run in silent evaluation first, so alert volume and precision are measured before clinicians are exposed to them.
Rollout and Ongoing Tuning
Rollout expands unit by unit with override monitoring, committee review, and active retirement of alert types producing noise rather than value.
Technology and Compliance
Medication safety software handles PHI and sits directly in the administration pathway, which raises the consequence of both false negatives and workflow friction. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Where checking logic guides clinical decisions, SaMD classification may apply. Two constraints deserve explicit statement. Software confirmation does not satisfy independent double-check requirements, which need a second clinician. And hard stops carry their own risk, since a blocked order in an emergency can delay necessary treatment.
HIPAA-Aligned Engineering
Builds apply encryption in transit and at rest, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these controls.
SaMD and FDA Considerations
Checking logic guiding clinical decisions may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation, and change control.
Double-Check Requirements
Independent double-check requires a second clinician. Software confirmation supports but does not satisfy that requirement, and we do not represent it otherwise.
Hard Stop Governance
Hard stops are configured only with clinical governance approval, since blocking an order carries risk when urgent treatment is genuinely indicated.
Override Documentation
Override reasons are captured structurally, giving your committee data on whether alerts are being dismissed appropriately or reflexively.
Deployment Security
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant discipline here is designing for the workaround. Medication safety technology fails predictably when it is slower than the shortcut, and a vendor that does not ask about your existing workarounds during discovery is not going to fix them. Our leadership brings more than 20 years of personal experience in the field.
01
Designed Around Workarounds
We identify existing workarounds during discovery, since staff bypass behavior is the clearest available evidence of where safeguards conflict with work.
02
Selective Alerting Discipline
We treat alert selectivity as a clinical decision made with your committee, because noisy safety systems produce dismissal rather than safety.
03
Honest Double-Check Framing
We state plainly that software confirmation does not replace independent verification, rather than implying a second clinician becomes unnecessary.
04
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical workflow.
05
EHR and Systems Integration
Our Voyant Health EHR and EMR work means ordering and administration integration is handled by engineers with clinical systems experience.
06
Certified Security Posture
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment efficiently.
Pricing
AI medication error prevention pricing depends on scope, which process steps are covered, device integration, and unit count. A dose range checking module costs considerably less than a system spanning ordering, verification, administration, pump integration, and alert governance. We price after discovery, because smart pump and device integration feasibility varies substantially by vendor and generation. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Cloud infrastructure, device interface fees, and drug database licensing are separate from engineering.
MVP or Single Module
An MVP covering dose range checking with pediatric logic typically runs $40,000 to $80,000, addressing the highest-consequence calculation risk first.
Full Platform Build
A full platform spanning ordering, verification, administration support, and alert governance typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering multi-facility standardization, pump integration, and full process coverage start at $200,000.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and override baseline assessment. It is separable so you can evaluate our work first.
Cost Drivers to Expect
Device integration feasibility, process steps covered, drug database licensing, and facility count are the largest variables, identified during discovery.
Ongoing Support Costs
Post-launch alert tuning, drug database updates, override monitoring, and support are quoted separately as a retainer sized to your facility count.
Get Started
If you are evaluating AI medication error prevention for dose range checking, verification workflow, barcode administration, or high-alert drug safeguards, the fastest next step is a discovery call with our team. We will review override rates, existing workarounds, and device integration feasibility, then return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Pharmacy and nursing leaders evaluating AI medication error prevention usually ask about alert burden, whether software satisfies double-check requirements, and how hard stops are handled. The answers below reflect how we scope these projects. If workarounds have already emerged around your existing systems, that is the most useful thing to discuss first.
Only if configured badly, which is the usual outcome and the thing we design against. Alert thresholds are set with your medication safety committee before launch, override rates are monitored by alert type, and alerts producing noise are retired rather than left running. Selectivity is the whole design problem.
No. Independent double-check requires a second clinician verifying independently, and software confirmation does not substitute for that. We support the workflow and document the check, but we will not represent automation as satisfying a requirement that exists precisely because independent human verification catches different errors.
Only with clinical governance approval, and sparingly. A hard stop blocking an order can delay genuinely urgent treatment, so blocking is reserved for situations where the potential harm clearly exceeds that risk. Most checking is advisory with documented override rather than blocking.
They will if scanning is slower than the alternative, which is why we test administration paths under real conditions and design fast exception handling. Workarounds are a design failure rather than a compliance problem, and we ask about existing ones during discovery for that reason.
An MVP covering dose range checking runs $40,000 to $80,000. A full platform spanning the medication process typically falls between $80,000 and $200,000. Enterprise multi-facility deployments with pump integration start at $200,000. Discovery produces an itemized, fixed-scope estimate.
Yes, as a distinct calculation path rather than an adjustment to adult logic. Pediatric dosing errors carry disproportionate consequence, and weight-based calculation with concentration and volume checking is handled explicitly rather than inherited from adult defaults.